Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulia Rech

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Pediatric Dermatology|March 1, 2018
Familial papular epidermal nevus with "skyline" basal cell layer and multiple pilomatricomas: A new association?Laura Rizzoli, Riccardo Balestri, Giulia Rech, et al.
Journal of Clinical Medicine|January 10, 2026
Unravelling the Mystery of Psoriasis Dermatitis (PsoDermatitis): A Practical Guide to Recognition and ManagementRiccardo Balestri, Michela Magnano, Salvatore Domenico Infusino, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 27, 2022
Analysis of current data on the use of topical mTOR inhibitors in the treatment of facial angiofibromas in tuberous sclerosis complex-An updateRiccardo Balestri, Laura Rizzoli, Annalisa Pedrolli, et al.
Journal of Personalized Medicine|January 27, 2026
Effectiveness of Bimekizumab in Multi-Failure Psoriatic Patients: A Retrospective, Real-World Multicenter StudyFrancesca Satolli, Giulia Rech, Silvia Gerosa, et al.
Dermatology Reports|March 18, 2026
Free access to medications for scabies treatment in Italy: a call to action and the need to evaluate its clinical and epidemiological impactCorrado Zengarini, Martina Mussi, Iria Neri, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 12, 2023
Safety profile of risankizumab in the treatment of psoriasis patients with concomitant hepatitis B or C infection: A multicentric retrospective cohort study of 49 patientsChristian Ciolfi, Riccardo Balestri, Federico Bardazzi, et al.
Drugs in Context|September 12, 2024
Rapid Efficacy of riSankizumab in pretibial psoriasis invOLVEment: RESOLVENicoletta Bernardini, Nevena Skroza, Laura Atzori, et al.
Journal of Clinical Medicine|July 13, 2024
Long-Term Persistence Rate of Secukinumab in Psoriatic Patients: A Six-Year Multicenter, Real-World Experience, Retrospective StudyMarco Galluzzo, Emanuele Trovato, Marina Talamonti, et al.
Clinical and Experimental Dermatology|June 16, 2025
Psoriasis vulgaris in patients with a recent history of neoplasia: safety of interleukin-23 inhibitors. A multicentre retrospective studyFrancesca Satolli, Silvia Gerosa, Martina Burlando, et al.
The Journal of Dermatology|April 16, 2025
Effectiveness of Dupilumab and Omalizumab in Bullous Pemphigoid: A Nationwide Retrospective Cohort StudyGianluca Avallone, Carlo Alberto Maronese, Martina Zussino, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Pediatric Dermatology|March 1, 2018
Familial papular epidermal nevus with "skyline" basal cell layer and multiple pilomatricomas: A new association?Laura Rizzoli, Riccardo Balestri, Giulia Rech, et al.
Journal of Clinical Medicine|January 10, 2026
Unravelling the Mystery of Psoriasis Dermatitis (PsoDermatitis): A Practical Guide to Recognition and ManagementRiccardo Balestri, Michela Magnano, Salvatore Domenico Infusino, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 27, 2022
Analysis of current data on the use of topical mTOR inhibitors in the treatment of facial angiofibromas in tuberous sclerosis complex-An updateRiccardo Balestri, Laura Rizzoli, Annalisa Pedrolli, et al.
Journal of Personalized Medicine|January 27, 2026
Effectiveness of Bimekizumab in Multi-Failure Psoriatic Patients: A Retrospective, Real-World Multicenter StudyFrancesca Satolli, Giulia Rech, Silvia Gerosa, et al.
Dermatology Reports|March 18, 2026
Free access to medications for scabies treatment in Italy: a call to action and the need to evaluate its clinical and epidemiological impactCorrado Zengarini, Martina Mussi, Iria Neri, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 12, 2023
Safety profile of risankizumab in the treatment of psoriasis patients with concomitant hepatitis B or C infection: A multicentric retrospective cohort study of 49 patientsChristian Ciolfi, Riccardo Balestri, Federico Bardazzi, et al.
Drugs in Context|September 12, 2024
Rapid Efficacy of riSankizumab in pretibial psoriasis invOLVEment: RESOLVENicoletta Bernardini, Nevena Skroza, Laura Atzori, et al.
Journal of Clinical Medicine|July 13, 2024
Long-Term Persistence Rate of Secukinumab in Psoriatic Patients: A Six-Year Multicenter, Real-World Experience, Retrospective StudyMarco Galluzzo, Emanuele Trovato, Marina Talamonti, et al.
Clinical and Experimental Dermatology|June 16, 2025
Psoriasis vulgaris in patients with a recent history of neoplasia: safety of interleukin-23 inhibitors. A multicentre retrospective studyFrancesca Satolli, Silvia Gerosa, Martina Burlando, et al.
The Journal of Dermatology|April 16, 2025
Effectiveness of Dupilumab and Omalizumab in Bullous Pemphigoid: A Nationwide Retrospective Cohort StudyGianluca Avallone, Carlo Alberto Maronese, Martina Zussino, et al.
Pageof 6